Article Text

Download PDFPDF
Systematic review and meta-analysis
Some oral antidiabetic medications may prevent Type 2 diabetes in people at high risk for it, but the evidence is insufficient to determine whether the potential benefits outweigh the possible risks

Statistics from


  • Competing interests AJK has received professional consultancy fees, grant funding and/or fees for consultancies and lectures from Astra Zeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, NovoNordisk, Pfizer, Servier and Takeda.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.